The precursor of Alzheimer's disease amyloid A4 protein resembles a cell-surface receptor
The DOI matches its Crossref record; 26 of the 26 references it cites were found in a registry or an index.
Abstract
Alzheimer's disease is characterized by a widespread functional disturbance of the human brain. Fibrillar amyloid proteins are deposited inside neurons as neurofibrillary tangles and extracellularly as amyloid plaque cores and in blood vessels. The major protein subunit (A4) of the amyloid fibril of tangles, plaques and blood vessel deposits is an insoluble, highly aggregating small polypeptide of relative molecular mass 4,500. The same polypeptide is also deposited in the brains of aged individuals with trisomy 21 (Down's syndrome). We have argued previously that the A4 protein is of neuronal origin and is the cleavage product of a larger precursor protein. To identify this precursor, we have now isolated and sequenced an apparently full-length complementary DNA clone coding for the A4 polypeptide. The predicted precursor consists of 695 residues and contains features characteristic of glycosylated cell-surface receptors. This sequence, together with the localization of its gene on chromosome 21, suggests that the cerebral amyloid deposited in Alzheimer's disease and aged Down's syndrome is caused by aberrant catabolism of a cell-surface receptor.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Molecular imaging studies such as those using amyloid positron emission tomography (PET) have shown that Aβ deposition reaches a plateau before brain atrophy can be identified from structural magnetic resonance imaging (MRI) and cognitive symptoms [15, 19].”
From Clinical trials of new drugs for Alzheimer disease (2020) · cites this paper as [15]
In the citing paper
“All the mutant genes of hereditary, autosomal, and dominant familial AD, including amyloid precursor protein (APP), presenilin 1, and presenilin 2, encode the major proteins involved in amyloid metabolism [14–16].”
From Clinical trials of new drugs for Alzheimer disease (2020) · cites this paper as [15]
In the citing paper
“Amyloid  protein (A), the principal protein in the senile plaques of Alzheimer's disease (AD), is an ϳ4 kDa secreted polypeptide”
From Age-Dependent Changes in Brain, CSF, and Plasma Amyloid β Protein in the Tg2576 Transgenic Mouse Model of Alzheimer's Disease (2001) · cites this paper as Kang et al., 1987
In the citing paper
“APP isoforms are encoded by several alternatively spliced transcripts (Kang et al., 1987;K itaguchi et al., 1988;Ponte et al., 1988;Tanzi et al., 1988;Golde et al., 1990;Ko ¨nig et al., 1992).”
From Alzheimer Amyloid Protein Precursor in the Rat Hippocampus: Transport and Processing through the Perforant Path (1998) · cites this paper as Kang et al., 1987
In the citing paper
“APP, first identified by Kang et al. [18], is a type I transmembrane protein with a long luminal N-terminal domain and a small cytoplasmic C-terminal tail [18,19].”
From Advances in the cell biology of the trafficking and processing of amyloid precursor protein: impact of familial Alzheimer's disease mutations (2024) · cites this paper as [18]
Citations
Cites
DNA sequencing with chain-terminating inhibitors
Sanger, F., Nicklen, S., & Coulson, A. R. (1977) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.74.12.5463 · Cited by 68,572
Detection of specific sequences among DNA fragments separated by gel electrophoresis
Southern, E. M. (1975) · Journal of Molecular Biology · doi:10.1016/s0022-2836(75)80083-0 · Cited by 32,249
Rigby, P. W. J., Dieckmann, M., Rhodes, C., & Berg, P. (1977) · Journal of Molecular Biology · doi:10.1016/0022-2836(77)90052-3 · Cited by 11,401
Hybridization of denatured RNA and small DNA fragments transferred to nitrocellulose.
Thomas, P. S. (1980) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.77.9.5201 · Cited by 8,156
Aviv, H., & Leder, P. (1972) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.69.6.1408 · Cited by 6,751
Amyloid plaque core protein in Alzheimer disease and Down syndrome.
Masters, C. L., Simms, G., Weinman, N. A., Multhaup, G., McDonald, B. L., & Beyreuther, K. (1985) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.82.12.4245 · Cited by 4,431
Self-citationLehrach, H., Diamond, D., Wozney, J. M., & Boedtker, H. (1977) · Biochemistry · doi:10.1021/bi00640a033 · Cited by 3,415
A gas-liquid solid phase peptide and protein sequenator.
Hewick, R. M., Hunkapiller, M. W., Hood, L. E., & Dreyer, W. J. (1981) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)43377-7 · Cited by 2,218
Alzheimer's disease and Down's syndrome: Sharing of a unique cerebrovascular amyloid fibril protein
Glenner, G. G., & Wong, C. W. (1984) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(84)91209-9 · Cited by 1,693
A cellular gene encodes scrapie PrP 27-30 protein
Oesch, B., Westaway, D., Wälchli, M., McKinley, M. P., Kent, S. B. H., Aebersold, R., Barry, R. A., Tempst, P., Teplow, D. B., Hood, L. E., et al. (1985) · Cell · doi:10.1016/0092-8674(85)90333-2 · Cited by 1,513
Research works printed but not linked: 4
- Alzheimer, A. Allg. Z. Psychiat. 64, 146–148 (1907).
- Katzman, R. (ed.) Biological Aspects of Alzheimer's Disease (Banbury Report 15) (Cold Spring Harbor Laboratory, New York, 1983).
- Beyreuther, K. et al. in Discussions in Neuroscience Vol. 3 (eds Bignami, A., Bolis, L. & Gajdusek, D. C. 68–79 Fondation pour I'Étude du Système Nerveux, Geneva (1986).
- Goldgaber, D., Lerman, M. I., McBride, W. O., Sallow, V. & Gajdusek, D. C. Science (in the press).
Cited by
Items 1,001–1,071 of 1,071
Lorton, D., Kocsis, J.-M., King, L., Madden, K., & Brunden, K. R. (1996) · Journal of Neuroimmunology · doi:10.1016/0165-5728(96)00030-6 · Cited by 112
“Senile plaques are associated with excessive deposition of a 40-42 amino acid peptide, P-amyloid (API, derived from a larger amyloid precursor protein (APP) (Glenner and Wong, 1984; Kang et al., 1987; Selko, 1991; Esch et al., 1990; Anderson et al.. 1991: Wang et al., 199 1).”
BackgroundMetalloprotease Meprin β Generates Nontoxic N-terminal Amyloid Precursor Protein Fragments in Vivo
Jefferson, T., Čaušević, M., auf dem Keller, U., Schilling, O., Isbert, S., Geyer, R., Maier, W., Tschickardt, S., Jumpertz, T., Weggen, S., et al. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.252718 · Cited by 108
Cam (2006) · Molecular Neurodegeneration · doi:10.1186/1750-1326-1-8 · Cited by 106
Nilselid, A.-M., Davidsson, P., Nägga, K., Andreasen, N., Fredman, P., & Blennow, K. (2006) · Neurochemistry International · doi:10.1016/j.neuint.2005.12.005 · Cited by 104
APP Function and Lipids: A Bidirectional Link
Grimm, M. O. W., Mett, J., Grimm, H. S., & Hartmann, T. (2017) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2017.00063 · Cited by 104
“Aβ-peptides are hydrophobic, 38–43 amino acid long products generated by the sequential proteolytic processing of the amyloid precursor protein (APP; Glenner and Wong, 1984; Masters et al., 1985; Kang et al., 1987).”
BackgroundAnti-Amyloid Therapies for Alzheimer’s Disease and the Amyloid Cascade Hypothesis
Fedele, E. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241914499 · Cited by 102
The Proteasome and Oxidative Stress in Alzheimer's Disease
Bonet-Costa, V., Pomatto, L. C.-D., & Davies, K. J. A. (2016) · Antioxidants & Redox Signaling · doi:10.1089/ars.2016.6802 · Cited by 99
“Importantly, a-secretase cleavage results in disruption (separation) of the Ab region, between lysine 16 and leucine 17 (78, 167).”
Aged Non‐Human Primates: An Animal Model of Age‐Associated Neurodegenerative Disease
Price, D. L., Martin, L. J., Sisodia, S. S., Wagster, M. V., Koo, E. H., Walker, L. C., Koliatsos, V. E., & Cork, L. C. (1991) · Brain Pathology · doi:10.1111/j.1750-3639.1991.tb00672.x · Cited by 100
Genetic Heterogeneity in Alzheimer Disease and Implications for Treatment Strategies
Dominantly Inherited Alzheimer Network, Ringman, J. M., Goate, A., Masters, C. L., Cairns, N. J., Danek, A., Graff-Radford, N., Ghetti, B., & Morris, J. C. (2014) · Current Neurology and Neuroscience Reports · doi:10.1007/s11910-014-0499-8 · Cited by 96
Self-citationThe cell cycle as a therapeutic target for Alzheimer's disease
Neve, R. L., & McPhie, D. L. (2006) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2005.09.005 · Cited by 92
Ugalde, C. L., Finkelstein, D. I., Lawson, V. A., & Hill, A. F. (2016) · Journal of Neurochemistry · doi:10.1111/jnc.13772 · Cited by 92
“naturally occurring cleavage product of the integral membrane protein, amyloid-b protein precursor (APP) (Kang et al. 1987), Ab is produced by the sequential cleavage by band c-secretases that cleave at various sites in APP, producing Ab peptides which differ by several amino acid lengths.”
BackgroundFelsenstein, K. M., Hunihan, L. W., & Roberts, S. B. (1994) · Nature Genetics · doi:10.1038/ng0394-251 · Cited by 90
Bukhari, H., Glotzbach, A., Kolbe, K., Leonhardt, G., Loosse, C., & Müller, T. (2017) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2017.05.005 · Cited by 88
Innate immune system and inflammation in Alzheimer’s disease: From pathogenesis to treatment
Serpente, M., Bonsi, R., Scarpini, E., & Galimberti, D. (2014) · Neuroimmunomodulation · doi:10.1159/000356529 · Cited by 87
Synaptophysin Is a Reliable Marker for Axonal Damage
Gudi, V., Gai, L., Herder, V., Tejedor, L. S., Kipp, M., Amor, S., Sühs, K.-W., Hansmann, F., Beineke, A., Baumgärtner, W., et al. (2017) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/nlw114 · Cited by 87
Mitochondrial Abnormalities in Alzheimer’s Disease
Silva, D. F., Selfridge, J. E., Lu, J., E, L., Cardoso, S. M., & Swerdlow, R. H. (2012) · Advances in Pharmacology · doi:10.1016/b978-0-12-394816-8.00003-9 · Cited by 86
“This promotes accumulation of Aβ aggregates, which may be formed by APP cleavage at AV membranes (F).”
BackgroundInfluentialLehman, E. J. H. (2003) · Human Molecular Genetics · doi:10.1093/hmg/ddg322 · Cited by 85
“Aβ is a 39- to 43- amino acid peptide derived from the proteolytic processing of APP (4).”
BackgroundCleavage of Amyloid-β Precursor Protein (APP) by Membrane-Type Matrix Metalloproteinases
Ahmad, M., Takino, T., Miyamori, H., Yoshizaki, T., Furukawa, M., & Sato, H. (2006) · The Journal of Biochemistry · doi:10.1093/jb/mvj054 · Cited by 82
“As its name implies, APP was initially identified as the precursor of amyloid b peptide (Ab), the principal component of amyloid plaques in the pathogenesis of Alzheimer’s disease (1).”
BackgroundComplement in Alzheimer's disease: opportunities for modulating protective and pathogenic events
Tenner, A. (2001) · Neurobiology of Aging · doi:10.1016/s0197-4580(01)00301-3 · Cited by 81
Saito, Y., Buciak, J., Yang, J., & Pardridge, W. M. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.22.10227 · Cited by 81
Ullah, R., Park, T. J., Huang, X., & Kim, M. O. (2021) · Ageing Research Reviews · doi:10.1016/j.arr.2021.101451 · Cited by 78
“Aβ peptides are integral components of the amyloid-beta precursor protein (AβPP) (Kang et al., 1987; Yankner and Mesulam, 1991).”
InfluentialOxidation of Aβ and Plaque Biogenesis in Alzheimer's Disease and Down Syndrome
Head, E., Garzon-Rodriguez, W., Johnson, J. K., Lott, I. T., Cotman, C. W., & Glabe, C. (2001) · Neurobiology of Disease · doi:10.1006/nbdi.2001.0431 · Cited by 75
“A major constituent of SP is the amyloid b protein (Ab), which is a 39- to 42-amino acid peptide cleaved from a longer amyloid precursor protein (APP) (Glenner & Wong, 1984; Kang et al., 1987).”
BackgroundEarly intraneuronal Aβ deposition in the hippocampus of APP transgenic mice
Shie, F.-S., LeBoeur, R. C., & Jin, L.-W. (2003) · NeuroReport · doi:10.1097/00001756-200301200-00023 · Cited by 70
Shigematsu, K., McGeer, P. L., & McGeer, E. G. (1992) · Brain Research · doi:10.1016/0006-8993(92)91697-d · Cited by 70
β-Amyloid precursor protein gene is differentially expressed in axotomized sensory and motor systems
Scott, J. N., Parhad, I. M., & Clark, A. W. (1991) · Molecular Brain Research · doi:10.1016/0169-328x(91)90090-k · Cited by 68
Han, S.-H., Park, J.-C., & Mook-Jung, I. (2016) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2015.12.004 · Cited by 67
Jackson, H. M., Soto, I., Graham, L. C., Carter, G. W., & Howell, G. R. (2013) · BMC Genomics · doi:10.1186/1471-2164-14-831 · Cited by 66
Increased senile plaques without microglia in Alzheimer's disease
Ohgami, T., Kitamoto, T., Shin, R. W., Kaneko, Y., Ogomori, K., & Tateishi, J. (1991) · Acta Neuropathologica · doi:10.1007/bf00305864 · Cited by 64
“The /~ protein is the cleavage product of a precursor resembling a cell-surface receptor [11].”
BackgroundMembrane dynamics, cholesterol homeostasis, and Alzheimer's disease
Chauhan, N. B. (2003) · Journal of Lipid Research · doi:10.1194/jlr.r300010-jlr200 · Cited by 64
Kessler, H., Pajonk, F.-G., Bach, D., Schneider-Axmann, T., Falkai, P., Herrmann, W., Multhaup, G., Wiltfang, J., Schäfer, S., Wirths, O., et al. (2008) · Journal of Neural Transmission · doi:10.1007/s00702-008-0136-2 · Cited by 61
“Potentially toxic Ab peptides are generated from the copper-binding APP by two independent proteolytic events (Bayer et al. 2001; Glenner and Wong 1984; Hesse et al. 1994; Kang et al. 1987).”
BackgroundSelf-citationFuller, O. K., Whitham, M., Mathivanan, S., & Febbraio, M. A. (2020) · Cells · doi:10.3390/cells9102182 · Cited by 60
In vivo imaging reveals sigmoidal growth kinetic of β-amyloid plaques
Burgold, S., Filser, S., Dorostkar, M. M., Schmidt, B., & Herms, J. (2014) · Acta Neuropathologica Communications · doi:10.1186/2051-5960-2-30 · Cited by 59
“Cloning of the amyloid precursor protein pioneered the investigation of Aβ aggregation in vitro [11].”
Campos-Peña, V., Toral-Rios, D., Becerril-Pérez, F., Sánchez-Torres, C., Delgado-Namorado, Y., Torres-Ossorio, E., Franco-Bocanegra, D., & Carvajal, K. (2017) · Antioxidants & Redox Signaling · doi:10.1089/ars.2016.6768 · Cited by 58
“The main component of NPs is a peptide of 39–42 amino acids with a molecular weight of 4 kDa, called A b (96, 97, 120, 191), which arises as a product of normal secretion of APP (126).”
Kaur, G., Sharma, A., Xu, W., Gerum, S., Alldred, M. J., Subbanna, S., Basavarajappa, B. S., Pawlik, M., Ohno, M., Ginsberg, S. D., et al. (2014) · The Journal of Neuroscience · doi:10.1523/jneurosci.5338-13.2014 · Cited by 58
“Down’s syndrome (DS) is a genetic disease caused by trisomy of human chromosome 21 (HSA21), associated with developmental brain abnormalities (Wisniewski et al., 1984; Lott, 2012) and early intellectual disabilities (Lott and Dierssen, 2010).”
BackgroundAkaaboune, M., Allinquant, B., Farza, H., Roy, K., Magoul, R., Fiszman, M., Festoff, B. W., & Hantaı̈, D. (2000) · Molecular and Cellular Neuroscience · doi:10.1006/mcne.2000.0834 · Cited by 58
Amyloid precursor protein mediates proinflammatory activation of monocytic lineage cells
Sondag, C. M., & Combs, C. K. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m313747200 · Cited by 56
The last neuronal division: a unifying hypothesis for the pathogenesis of Alzheimer's disease
Nagy, Z. (2005) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2005.tb00485.x · Cited by 56
“The analysis of its primary structure led to the suggestion that APP might be a glycosilated cell surface receptor [15] while later studies showed that APP itself might be one of the cell surface mediators of β-amyloid toxicity [16].”
BackgroundInsights into the Phosphoregulation of β‐Secretase Sorting Signal by the VHS Domain of GGA1
Shiba, T., Kametaka, S., Kawasaki, M., Shibata, M., Waguri, S., Uchiyama, Y., & Wakatsuki, S. (2004) · Traffic · doi:10.1111/j.1600-0854.2004.00188.x · Cited by 56
“A proteinase with b-secretase activity has recently been cloned and is referred to as BACE (beta-site of APP cleaving enzyme) (4,5).”
BackgroundAlterations in β-amyloid production and deposition in brain regions of two transgenic models
Lehman, E. J. H., Kulnane, L. S., & Lamb, B. T. (2003) · Neurobiology of Aging · doi:10.1016/s0197-4580(02)00153-7 · Cited by 55
“A is derived from APP, a protein of unknown function with at least four tissue-specific protein isoforms of 695, 714, 751 and 770 amino acids [10,18].”
BackgroundAntonios, G., Saiepour, N., Bouter, Y., Richard, B. C., Paetau, A., Verkkoniemi-Ahola, A., Lannfelt, L., Ingelsson, M., Kovacs, G. G., Pillot, T., et al. (2013) · Acta Neuropathologica Communications · doi:10.1186/2051-5960-1-56 · Cited by 53
Shedding of APP limits its synaptogenic activity and cell adhesion properties
Stahl, R., Schilling, S., Soba, P., Rupp, C., Hartmann, T., Wagner, K., Merdes, G., Eggert, S., & Kins, S. (2014) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2014.00410 · Cited by 53
“Amyloid-β is derived from the amyloid precursor protein (APP; Kang et al., 1987) by sequential cleavages of β- and γ-secretase.”
BackgroundCSF tau and β-amyloid as biomarkers for mild cognitive impairment
Hampel, H., & Blennow, K. (2004) · Dialogues in Clinical Neuroscience · doi:10.31887/dcns.2004.6.4/hhampel · Cited by 52
Splice variants of the β-site APP-cleaving enzyme BACE1 in human brain and pancreas
Ehehalt, R., Michel, B., De Pietri Tonelli, D., Zacchetti, D., Simons, K., & Keller, P. (2002) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(02)00169-9 · Cited by 51
“Ab is produced by proteolytic cleavage from the amyloid precursor protein (APP), a transmembrane protein with a large N-terminal ectodomain and a short C-terminal cytoplasmic tail [1].”
BackgroundIs the "preamyloid" of diffuse plaques in Alzheimer's disease really nonfibrillar?
(1993) · PubMed Central · Cited by 49
Differential splicing and glycosylation of Apoer2 alters synaptic plasticity and fear learning
Wasser, C. R., Masiulis, I., Durakoglugil, M. S., Lane-Donovan, C., Xian, X., Beffert, U., Agarwala, A., Hammer, R. E., & Herz, J. (2014) · Science Signaling · doi:10.1126/scisignal.2005438 · Cited by 48
“Amyloid plaques are aggregates of amyloid-β (1, 2), a product of amyloid precursor protein (APP) cleavage (3).”
Kametaka, S., Shibata, M., Moroe, K., Kanamori, S., Ohsawa, Y., Waguri, S., Sims, P. J., Emoto, K., Umeda, M., & Uchiyama, Y. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m208611200 · Cited by 47
Ayton, S., & Bush, A. I. (2021) · Ageing Research Reviews · doi:10.1016/j.arr.2020.101212 · Cited by 45
Capetillo-Zarate, E., Staufenbiel, M., Abramowski, D., Haass, C., Escher, A., Stadelmann, C., Yamaguchi, H., Wiestler, O. D., & Thal, D. R. (2006) · Brain · doi:10.1093/brain/awl176 · Cited by 45
“Ab is derived from the amyloid precursor protein (APP) (Kang et al., 1987).”
BackgroundKnockdown of Amyloid Precursor Protein: Biological Consequences and Clinical Opportunities
Gabriele, R. M. C., Abel, E., Fox, N. C., Wray, S., & Arber, C. (2022) · Frontiers in Neuroscience · doi:10.3389/fnins.2022.835645 · Cited by 44
“Structure and Expression APP was first cloned in 1987 (Kang et al., 1987), prior to the discovery of genetic polymorphisms associated with familial AD (Hardy and Allsop, 1991).”
BackgroundMechanisms of memory loss in Aβ and tau mouse models
Ashe, K. H. (2005) · Biochemical Society Transactions · doi:10.1042/bst0330591 · Cited by 42
Savage, M. J., Iqbal, M., Loh, T., Trusko, S. P., Scott, R., & Siman, R. (1994) · Neuroscience · doi:10.1016/0306-4522(94)90490-1 · Cited by 42
Abramowski, D., Rabe, S., Upadhaya, A. R., Reichwald, J., Danner, S., Staab, D., Capetillo-Zarate, E., Yamaguchi, H., Saido, T. C., Wiederhold, K.-H., et al. (2012) · The Journal of Neuroscience · doi:10.1523/jneurosci.4586-11.2012 · Cited by 41
“Within APP, the N terminus of the A peptide is located in the lumen of the intracellular membrane systems, while its C terminus resides in the center of the transmembrane region (Kang et al., 1987).”
BackgroundNeurotoxicity of Aβ amyloid protein in vitro is not altered by calcium channel blockade
Whitson, J. S., & Appel, S. H. (1995) · Neurobiology of Aging · doi:10.1016/0197-4580(95)80002-9 · Cited by 41
An apolipoprotein E4 fragment can promote intracellular accumulation of amyloid peptide beta 42
Dafnis, I., Stratikos, E., Tzinia, A., Tsilibary, E. C., Zannis, V. I., & Chroni, A. (2010) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2010.06756.x · Cited by 41
“Effect of truncated apoE4 forms on APP processing and Ab levels in SK-N-SH and HEK293 cells transiently transfected with human APP To study the effect of truncated apoE4 forms on APP processing and extracellular Ab levels, human neuroblastoma SK-N-SH cells were transiently transfected with human APP695, which is the A…”
MethodApoER2 processing by presenilin-1 modulates reelin expression
Balmaceda, V., Cuchillo‐Ibáñez, I., Pujadas, L., García‐Ayllón, M., Saura, C. A., Nimpf, J., Soriano, E., & Sáez‐Valero, J. (2014) · The FASEB Journal · doi:10.1096/fj.13-239350 · Cited by 40
Receptor Recycling by Retromer
Carosi, J. M., Denton, D., Kumar, S., & Sargeant, T. J. (2023) · Molecular and Cellular Biology · doi:10.1080/10985549.2023.2222053 · Cited by 36
Cheng, L., Li, W., Chen, Y., Lin, Y., Wang, B., Guo, Q., & Miao, Y. (2022) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp-2021-327864 · Cited by 36
Pathophysiological function of ADAMTS enzymes on molecular mechanism of Alzheimer’s disease
Gurses, M. S., Ural, M. N., Gulec, M. A., Akyol, O., & Akyol, S. (2016) · Aging and disease · doi:10.14336/ad.2016.0111 · Cited by 35
Su, R., Han, Z.-Y., Fan, J.-P., & Zhang, Y.-L. (2010) · Neuroscience Bulletin · doi:10.1007/s12264-010-0131-0 · Cited by 27
Wang, J., Fourriere, L., & Gleeson, P. A. (2024) · Biochemical Journal · doi:10.1042/bcj20240056 · Cited by 27
Cerebrospinal Fluid Biomarkers in Alzheimer’s Disease—From Brain Starch to Bench and Bedside
Pawlowski, M., Meuth, S., & Duning, T. (2017) · Diagnostics · doi:10.3390/diagnostics7030042 · Cited by 25
Studies on the first described Alzheimer's disease amyloid β mutant, the Dutch variant
Levy, E., Prelli, F., & Frangione, B. (2006) · Journal of Alzheimer's Disease · doi:10.3233/jad-2006-9s337 · Cited by 24
“Isolation of the amyloid protein enabled cloning of the gene revealing that A β is part of a larger amyloid β protein precursor (A β PP) [43,64,66,100,116].”
(2002) · PubMed · Cited by 24
Widespread γ-secretase activity in the cell, but do we need it at the mitochondria?
Teng, F. Y. H., & Tang, B. L. (2005) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2004.12.131 · Cited by 21
Do Microglia default on network maintenance in Alzheimer's disease?
Southam, K. A., Vincent, A. J., & Small, D. H. (2016) · Journal of Alzheimer s Disease · doi:10.3233/jad-151075 · Cited by 20
“A is cleaved from the larger amyloidprotein precursor (A PP) [4–6].”
BackgroundPapadopoulos, N., Suelves, N., Perrin, F., Vadukul, D. M., Vrancx, C., Constantinescu, S. N., & Kienlen-Campard, P. (2022) · Biomedicines · doi:10.3390/biomedicines10112753 · Cited by 20
“After the discovery that Aβ was the main component of AD amyloid fibrils [26] and subsequent identification of APP [19,27] and APLPs [22,28,29] genes, extensive studies in knock-out models brought the assumption that APP, APLP1, and APLP2 are partially functionally redundant (for a review see [30]).”
BackgroundMartá-Ariza, M., Leitner, D. F., Kanshin, E., Suazo, J., Giusti Pedrosa, A., Thierry, M., Lee, E. B., Devinsky, O., Drummond, E., Fortea, J., et al. (2025) · Acta Neuropathologica · doi:10.1007/s00401-025-02844-z · Cited by 15
KAPLITT, M., GOURAS, G. K., MAKIMURA, H., JOVANOVIC, J., SWEENEY, D., GREENGARD, P., RELKIN, N. R., & GANDY, S. (1996) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1996.tb32597.x · Cited by 12
Early onset Alzheimer's disease in a South American pedigree from Argentina
Mangone, C. A., Castaño, E. M., Levy, E., Abiusi, G., Wisniewski, T., Marques, M. R., Faccio, E., Gorelick, P. B., Frangione, B., & Sica, R. E. P. (1995) · Acta Neurologica Scandinavica · doi:10.1111/j.1600-0404.1995.tb05835.x · Cited by 10
Axonal Terminals Exposed to Amyloid-β May Not Lead to Pre-Synaptic Axonal Damage
Sun, S.-W., Nishioka, C., Labib, W., & Liang, H.-F. (2015) · Journal of Alzheimer’s Disease · doi:10.3233/jad-142154 · Cited by 8
“(cid:1) proteolysis of amyloid-(cid:1) protein precursor (A (cid:1) PP) [9–11 and possibly released from axonal terminals into the axonal terminal associated A (cid:1) can cause retrograde axonal degeneration, recent cell culture studies using microfluidic devices have demonstrated that…”
Targeting hippocampal amyloidogenesis with SV2A protein modulator levetiracetam
Kasatkina, L. A., Gumenyuk, V. P., Lisakovska, O. O., & Trikash, I. O. (2022) · Biochemical Pharmacology · doi:10.1016/j.bcp.2022.114927 · Cited by 7
Metadata
- Authors
- Kang, J., Lemaire, H.-G., Unterbeck, A., Salbaum, J. M., Masters, C. L., Grzeschik, K.-H., Multhaup, G., Beyreuther, K., & Müller-Hill, B.
- Affiliations
- University of Cologne (DE)
- Venue
- Nature
- Published
- 1987-02
- Volume
- 325
- Issue
- 6106
- Pages
- 733-736
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W2081881251
- Cited by
- 4,619
- References
- 26
- Citations by year
- 2026: 38 · 2025: 58 · 2024: 63 · 2023: 71 · 2022: 54 · 2021: 79 · 2020: 82 · 2019: 76 · 2018: 76 · 2017: 98 · 2016: 111 · 2015: 90 · 2014: 97 · 2013: 119 · 2012: 126
- FWCI
- 164.88
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Keywords
- Alzheimer's disease, amyloid precursor protein, cell surface receptors, Down syndrome, amyloid plaques, neurofibrillary tangles, chromosome 21, cDNA cloning, protein sequences
- MeSH terms
- Alzheimer Disease, Amyloid, Base Sequence, Brain, Brain Chemistry, Chromosomes, Human, Pair 21, DNA, Down Syndrome, Fetus, Humans, Neurofibrils, Nucleic Acid Hybridization, Protein Precursors, Protein Processing, Post-Translational, RNA, Messenger, Amyloid beta-Peptides, Amyloid beta-Protein Precursor
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.